249 related articles for article (PubMed ID: 31983359)
1. Multi-drug resistant spinal tuberculosis-epidemiological characteristics of in-patients: a multicentre retrospective study.
Yang S; Yu Y; Ji Y; Luo DJ; Zhang ZY; Huang GP; He FY; Wu WJ; Mou XP
Epidemiol Infect; 2020 Jan; 148():e11. PubMed ID: 31983359
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Study of 967 Patients With Spinal Tuberculosis.
Shi T; Zhang Z; Dai F; Zhou Q; He Q; Luo F; Hou T; Xu J
Orthopedics; 2016 Sep; 39(5):e838-43. PubMed ID: 27172367
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z
PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
[TBL] [Abstract][Full Text] [Related]
5. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China.
Guo Q; Pan Y; Yang Z; Liu R; Xing L; Peng Z; Zhu C
PLoS One; 2016; 11(3):e0151303. PubMed ID: 26959480
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
9. Improvement in clinical outcome and infection control using molecular diagnostic techniques for early detection of MDR tuberculous spondylitis: a multicenter retrospective study.
Wu W; Lyu J; Cheng P; Cheng Y; Zhang Z; Li L; Zheng Y; Xu J
Emerg Microbes Infect; 2017 Nov; 6(11):e97. PubMed ID: 29116218
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China.
Xu C; Pang Y; Li R; Ruan Y; Wang L; Chen M; Zhang H
J Infect; 2018 Apr; 76(4):348-353. PubMed ID: 29374587
[TBL] [Abstract][Full Text] [Related]
11. Multi-drug resistant tuberculosis burden and risk factors: an update.
Marahatta SB
Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China.
Wang Z; Hou Y; Guo T; Jiang T; Xu L; Hu H; Zhao Z; Xue Y
Front Public Health; 2023; 11():1117101. PubMed ID: 37228738
[TBL] [Abstract][Full Text] [Related]
13. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
[TBL] [Abstract][Full Text] [Related]
15. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
[TBL] [Abstract][Full Text] [Related]
17. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of skeletal tuberculosis in Beijing, China: a 10-year retrospective analysis of data.
Fan J; An J; Shu W; Huo F; Li S; Wang F; Qin S; Pang Y
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2019-2025. PubMed ID: 32556926
[TBL] [Abstract][Full Text] [Related]
19. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
